IDEX Corporation (NYSE: IEX) has reported its financial results for the fourth quarter and full year ended December 31, 2025. The company achieved record sales of $899 million in the fourth quarter, marking a 4% increase from the same period in 2024. Additionally, the reported diluted earnings per share (EPS) increased by 6% to $1.71, while adjusted diluted EPS grew by 3% to $2.10.
For the full year 2025, IDEX Corporation saw a 6% increase in reported sales, reaching $3.5 billion. However, reported diluted EPS decreased by 3% to $6.41, while adjusted diluted EPS increased by 1% to $7.95. Operating cash flow grew by 2% to $680 million, representing 141% of net income, up from 132% in the prior year. Free cash flow also increased by 2% to $617 million, with a conversion rate of 103%, up from 101%.
Looking ahead to 2026, the company projects a 1% to 2% increase in full-year organic sales over the prior year, with adjusted diluted EPS expected to range between $8.15 and $8.35. In the first quarter of 2026, organic sales are projected to increase by approximately 1% from the prior year period, with adjusted diluted EPS anticipated to be between $1.73 and $1.78.
Segment highlights for the fourth quarter show that the Health & Science Technologies (HST) segment experienced a 9% increase in net sales, driven by a 5% increase in organic sales. The Fluid & Metering Technologies segment saw a 2% increase in net sales, with a 1% increase in organic sales. However, the Fire & Safety/Diversified Products segment reported a 3% decrease in net sales, driven by a 5% decrease in organic sales.
The company also provided insights into the factors contributing to the changes in its financial metrics. It attributed the increase in net sales to contributions from acquisitions, organic sales, and favorable impacts from foreign currency. Additionally, operational productivity improvements and lower fair value inventory step-up charges were identified as drivers of gross margin improvement.
IDEX Corporation's CEO and President, Eric D. Ashleman, expressed confidence in the company's performance and its strategy of building focused growth platforms. He highlighted the increased demand for AI-related projects in the HST segment and emphasized the company's commitment to executing its growth and margin expansion strategy.
The full report, including detailed financial information and segment-specific performance, can be accessed on the company's investor relations site.
IDEX Corporation will host its fourth quarter earnings conference call on February 4, 2026, providing an opportunity for stakeholders to gain further insights into the company's financial results and outlook for the future. Today the company's shares have moved 0.83% to a price of $196.93. For the full picture, make sure to review IDEX CORP /DE/'s 8-K report.
